370 results on '"Raaphorst, Joost"'
Search Results
2. Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group
3. Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy
4. The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working group
5. Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
6. Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial
7. Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
8. Comprehensive overview of autoantibody isotype and subclass distribution
9. Clinical characteristics and outcome in muscular sarcoidosis: a retrospective cohort study and literature review
10. Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies
11. Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
12. Patient‐reported daily functioning after SARS‐CoV‐2 vaccinations in autoimmune neuromuscular diseases.
13. Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis
14. Cortical and subcortical changes in resting-state neuronal activity and connectivity in early symptomatic ALS and advanced frontotemporal dementia
15. Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases
16. A visual brain-computer interface as communication aid for patients with amyotrophic lateral sclerosis
17. Screening for cognition in amyotrophic lateral sclerosis: test characteristics of a new screen
18. Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy
19. De Novo and Bi-allelic Pathogenic Variants in NARS1 Cause Neurodevelopmental Delay Due to Toxic Gain-of-Function and Partial Loss-of-Function Effects
20. Characterization of EEG-based functional brain networks in myotonic dystrophy type 1
21. TCRβ clones in muscle tissue share structural features in patients with idiopathic inflammatory myopathy and are associated with disease activity
22. High incidence of falls in patients with myotonic dystrophy type 1 and 2: A prospective study
23. Affective symptoms and apathy in myotonic dystrophy type 1 a systematic review and meta-analysis
24. Structural white matter networks in myotonic dystrophy type 1
25. Motor neuron symptoms and pathology burden in de medulla oblongata of FTLD‐TDP brain donors
26. Experiences with bariatric surgery in patients with facioscapulohumeral dystrophy and myotonic dystrophy type 1: A qualitative study
27. Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial
28. Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study
29. The cognitive profile of myotonic dystrophy type 1: A systematic review and meta-analysis
30. Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
31. Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases:long-term humoral immune responses and effects on disease activity
32. Japanese version of the ALS-FTD-Questionnaire (ALS-FTD-Q-J)
33. Reader response: ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS
34. Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial
35. Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases
36. Immunosuppressive and immunomodulatory therapies for idiopathic inflammatory myopathies
37. Multimodality Screening For (Peri)Myocarditis In Newly Diagnosed Idiopathic Inflammatory Myopathies: A Cross-Sectional Study
38. Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
39. Longitudinal Dynamics of the SARS-CoV-2 Antibody Repertoire after SARS-CoV-2 Delta and Omicron Breakthrough Infections in Patients with Immune-Mediated Inflammatory Diseases
40. Additional file 1 of Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
41. Frontotemporal Syndrome in Amyotrophic Lateral Sclerosis: A Longitudinal MRI Study within One Year of Symptom Onset
42. No association between gluten sensitivity and amyotrophic lateral sclerosis
43. Integrin α7 Mutations Are Associated With Adult‐Onset Cardiac Dysfunction in Humans and Mice
44. B-cell receptor profiling before and after IVIG monotherapy in newly diagnosed idiopathic inflammatory myopathies
45. Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis
46. B-cell receptor profiling before and after IVIG monotherapy in newly diagnosed idiopathic inflammatory myopathies.
47. The frontotemporal syndrome of ALS is associated with poor survival
48. Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases
49. Cortical and subcortical changes in resting-state neuronal activity and connectivity in early symptomatic ALS and advanced frontotemporal dementia
50. Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.